Connect with us

coronavirus

EMA recommends Novavax COVID vaccine for adolescents

SHARE:

Published

4 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Novavax logo and two Vials labeled "VACCINE Coronavirus Covid-19".

Thursday's (23 June) advisory committee to the European Union drug regulator recommended that Novavax Inc's COVID-19 vaccine be expanded for adolescents 12-17 years old.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending